RXDX 199.92 (+0%)
US74349U1088BiotechnologyBiotechnology

Prometheus Biosciences (RXDX) Stock Highlights

199.92 | +0%
2023-07-19 20:20:32
Prometheus Biosciences Inc is a biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment and diagnosis of IBD.

Statistics

Range Today
199.92 199.92
Volume Today 0
Range 1 Year
24.32 199.98
Volume 1 Year 199.41M
Range 3 Year
16.11 199.98
Volume 3 Year 280.87M
Range 10 Year
16.11 199.98
Volume 10 Year 280.87M

Highlights

Market Capitalization 9.56B (mid)
Floating Shares 33.23M
Current Price 199.92
Price To Earnings -56.41
Price To Revenue 2.22K
Price To Book 13.67
Earnings Per Share -3.54
Payout Ratio 0%

Performance

Latest 0%
1 Month +3.59%
3 Months +69.45%
6 Months +83.09%
1 Year +722.04%
3 Years +701.28%
5 Years +701.28%
10 Years +701.28%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.